Hormonal and Allosteric Regulation of the Luteinizing Hormone/Chorionic Gonadotropin Receptor.
Level 5 - mechanism / opinion, no new human data
Narrative review of receptor mechanisms and pharmacology without systematic search or new human data
PubMed 39344322 · doi:10.31083/j.fbl2909313
What was done
This narrative review summarizes literature on the hormonal and allosteric regulation of the luteinizing hormone/chorionic gonadotropin receptor (LHCGR). It examines receptor interactions with heterotrimeric G proteins (Gs, Gq/11, Gi) and beta-arrestins, the role of ligand glycosylation, receptor dimerization, cellular microenvironments, autoantibodies, and the therapeutic potential of low-molecular-weight allosteric modulators.
What was found
The abstract provides qualitative mechanistic descriptions and reports no quantitative data or numerical outcomes. It details how LH and CG differentially engage downstream pathways (including cAMP-dependent, phospholipase, and MAP kinase cascades) and notes that allosteric sites across distinct LHCGR loci modulate signaling efficiency and selectivity.
Why it matters
Understanding the allosteric mechanisms and signaling pathways of LHCGR informs the rational design of low-molecular-weight pharmacological agents for reproductive disorders and assisted reproductive technologies.
Limits
As a narrative review, it presents no original experimental data, quantitative effect estimates, or systematic review methodology. Proposed clinical applications of allosteric modulators remain conceptual based on preclinical mechanistic models.
Cited by
- supports Human chorionic gonadotropin (hCG) and luteinizing hormone (LH) share the same cellular receptor.